5 ms·
Let's tackle recruitment. I've seen trials recruit really fast and that took a month. It's not like someone says "hey I'd like to take part in this trial" and
by refurb 7y ago
Let's tackle recruitment. I've seen trials recruit really fast and that took a month. It's not like someone says "hey I'd like to take part in this trial" and you give them a shot of drug. You need to screen everyone who comes in. Basic labs, then make sure they don't have some other disease that will mess up the results. That's just one part of it.
Then in terms of the trial, 6 months would be nice, but it wouldn't be ethical to actually expose them to the virus. You'd simply need to recruit a very large number of patients and see if the treatment groups has less disease than the non-treated group. With infection rates pretty low across the entire population, you'd need to recruit thousands, just to capture the handful that actually get exposed.
Then when it comes to analysis, you need to clean the data (yes, there will be errors), then you need to do a statistical analysis of not only efficacy but every possible side effect. You're probably measuring things like viral shedding, so that's another entire dataset. Oh, then you'll have missing data. Do you toss that patient's data out entirely? Or keep them? What impact does that have on your conclusion?
I could go on and on, but suffice to say it's a ton of work. And yes, you can speed up some parts, but other parts you just have to let them run their course.
- dantillberg 7y agoIf tens or hundreds of thousands of people were dying every day from the virus, might we find many volunteers willing to be intentionally exposed to the virus in order to rapidly test the efficacy of a vaccine? I imagine so. I believe the magnitude of this pandemic will in time push us (rather violently) to think outside the box.
- majewsky 7y agoEven if volunteers take the vaccine, this will not significantly change the timeline. Do you really want to cut short the observation time to e.g. 1 month, then greenlight the vaccine and administer it to millions or billions of people, only to find out that after 6 months it causes an aneurysm or whatever in 10% of them?
- refurb 7y agoThat's a key issue. If you're testing a drug for a serious cancer, then there is a lot of tolerance for side effects - the alternative is death, so even if it causes things like nerve damage, it's an acceptable risk. With vaccines, you're going to treat a huge percentage of the population and they'll be healthy when you give it to them. As such, the risk-benefit analysis is much different since there is a chance for serious harm.
- trashtester 7y agoStart by 100 people, monitor for 1 month. If it looks promising, add 1000 people, monitor for 1 month. If it looks promising, add 10000 people, monitor for 1 month. If it looks promising, add 100000 people, monitor for 1 month. If it looks promising, add 1000000 people, monitor for 1 month. And so on. The exact rate could be set according to the actual infection and death rates in the population. Given the current costs of curfew, we could create an entire government agency just to administer this, and still save trillions. For inspiration, consider the Manhatten project.
- ahpearce 7y ago> rapidly test the efficacy of a vaccine How do you test the efficacy if you don't know who you're injecting? Maybe it works really well on a certain population, and reacts harmfully to people with some pre-existing genetic trait or condition. You wouldn't know, because you took a random set of volunteers. If you're going to counter and say "we'd still do the pre-analysis on the volunteers"... Well, that's what takes time.
- WalterBright 7y ago> Let's tackle recruitment. I've seen trials recruit really fast and that took a month. It's not like someone says "hey I'd like to take part in this trial" and you give them a shot of drug. You need to screen everyone who comes in. Basic labs, then make sure they don't have some other disease that will mess up the results. You could do that time-consuming screening after they get the trial vaccine, not before. After all, I suspect it is highly unlikely that a virus vaccine would give someone a bacterial disease or a genetic disorder. Also, before the 6 month trial is up, you're still going to have data trickling in that will give a good indication whether it's working or not. Source: I saw the movie "Contagion" and learned that a vaccine is considered safe and effective based on one monkey not getting sick. I believe everything celebrities tell me.
- refurb 7y agoYou could do that time-consuming screening after they get the trial vaccine, not before. After all, I suspect it is highly unlikely that a virus vaccine would give someone a bacterial disease or a genetic disorder. Ok. So let’s say you give the vaccine and run the tests later. This person’s white blood cell count is way above normal. Is that caused by the vaccine? Was it something else? Was it always there? You have no idea because you didn’t capture a baseline. The challenge of clinical trials is you don’t know what to expect, and you’re measuring effects on top all the stuff that’s happening in the background with completely healthy people. The goal is to capture as much data as possible so you can actually draw conclusions from it. Otherwise you’re left thinking “it’s probably the drug, but I’m not sure”.
- WalterBright 7y ago> The goal is to capture as much data as possible Normally, yes. But this isn't normally - here the goal is to get a vaccine as quickly as possible. For example, white blood cell counts. Draw the blood, set it aside, inject the vaccine. Then get around to testing the blood. You save what, a week that way? That's a big deal. Based on your descriptions, it seems that a lot of time can be saved by doing things concurrently rather than serially.
- wbl 7y agoLow infection rates will not be your problem with this one I'm afraid.